Wealth Enhancement Advisory Services LLC Buys 635 Shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Wealth Enhancement Advisory Services LLC lifted its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 8.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,364 shares of the company’s stock after buying an additional 635 shares during the period. Wealth Enhancement Advisory Services LLC owned approximately 0.28% of Invesco Pharmaceuticals ETF worth $691,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Bank of America Corp DE grew its stake in Invesco Pharmaceuticals ETF by 5.4% during the fourth quarter. Bank of America Corp DE now owns 45,825 shares of the company’s stock worth $3,786,000 after buying an additional 2,336 shares in the last quarter. Focus Partners Wealth acquired a new stake in Invesco Pharmaceuticals ETF during the fourth quarter worth about $488,000. Bank of Montreal Can grew its stake in Invesco Pharmaceuticals ETF by 48.7% during the fourth quarter. Bank of Montreal Can now owns 1,044 shares of the company’s stock worth $86,000 after buying an additional 342 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Invesco Pharmaceuticals ETF by 6.3% during the fourth quarter. JPMorgan Chase & Co. now owns 4,301 shares of the company’s stock worth $355,000 after buying an additional 255 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Invesco Pharmaceuticals ETF during the fourth quarter worth about $943,000.

Invesco Pharmaceuticals ETF Stock Up 0.5%

Shares of Invesco Pharmaceuticals ETF stock opened at $82.51 on Wednesday. The company has a market capitalization of $242.58 million, a price-to-earnings ratio of 20.79 and a beta of 0.51. Invesco Pharmaceuticals ETF has a 12-month low of $72.25 and a 12-month high of $89.87. The firm’s 50-day moving average price is $79.14 and its two-hundred day moving average price is $82.96.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.